The UK medicines regulator has approved Moderna’s Covid-19 vaccine for emergency against the virus.
U.S. Food and Drug Administration has given emergency use authorization to Moderna Inc’s coronavirus vaccine.
The Chief Commissioner of the US FDA has stated that the organisation is working to approve Moderna's coronavirus vaccine.
Moderna Inc, has said that the company has the capacity to produce up to 500 million coronavirus vaccines by 2021.
The EU and the UK have expressed interest in securing Moderna's COVID-19 vaccine whose success was recently announced.
Moderna Inc's vaccine has been reported to be 94.5% effective as it prevented virtually all symptomatic cases of Covid-19 during trial.
The US said it is likely to have enough safe and effective COVID-19 vaccines to inoculate Americans by the end of 2020.
Moderna said the FDA will determine the health-risk of vaccine.
The drug developer is the fifth company to have concluded discussions with the EU.
The company wants to take up the question of one or two doses in its first phase of trial.